GenoFocus Inc Total Liabilities

Latest as of March 2026: ₩82.66 Billion KRW ≈ $56.02 Million USD

GenoFocus Inc total liabilities. Based on the latest financial reports, GenoFocus Inc (187420) has total liabilities worth ₩82.66 Billion KRW (≈ $56.02 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 187420 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of GenoFocus Inc (2014–2025)

Total liabilities of GenoFocus Inc from 2014 to 2025. This chart illustrates how GenoFocus Inc's total liabilities have evolved over time, based on quarterly financial data. Explore GenoFocus Inc (187420) investment intensity to see how much of total assets are deployed in long-term investments.

GenoFocus Inc Competitors by Total Liabilities

The table below lists competitors of GenoFocus Inc ranked by their total liabilities.

Company	Country	Total Liabilities
MODULIGHT OY EO 1 F:78W	Germany	€4.01 Million
Krynica Vitamin SA WAR:KVT	Poland	zł104.22 Million
Sino Tactful Co Ltd TWO:5481	Taiwan	NT$362.13 Million
Australian Unity Office Fund AU:AOF	Australia	AU$815.00K
Decidr Ai Industries Ltd AU:DAI	Australia	AU$17.13 Million
Intellicheck Mobilisa Inc NASDAQ:IDN	USA	$3.08 Million
MeVis Medical Solutions AG XETRA:M3V	Germany	€5.34 Million
Caprice Resources Limited F:C3F	Germany	€375.09K

Liability Composition Analysis (2014–2025)

This chart breaks down GenoFocus Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of GenoFocus Inc.

Liquidity & Leverage Metrics

GenoFocus Inc Total Liabilities Ratios Explained

GenoFocus Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	0.82	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.10	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.61	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how GenoFocus Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for GenoFocus Inc (2014–2025)

The table below shows the annual total liabilities of GenoFocus Inc from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩81.08 Billion ≈ $54.95 Million	-33.81%
2024-12-31	₩122.49 Billion ≈ $83.01 Million	+71.31%
2023-12-31	₩71.50 Billion ≈ $48.46 Million	-35.01%
2022-12-31	₩110.02 Billion ≈ $74.56 Million	+32.17%
2021-12-31	₩83.24 Billion ≈ $56.41 Million	+13.32%
2020-12-31	₩73.46 Billion ≈ $49.78 Million	+92.90%
2019-12-31	₩38.08 Billion ≈ $25.81 Million	+276.16%
2018-12-31	₩10.12 Billion ≈ $6.86 Million	+70.65%
2017-12-31	₩5.93 Billion ≈ $4.02 Million	+735.70%
2016-12-31	₩709.87 Million ≈ $481.07K	-3.57%
2015-12-31	₩736.18 Million ≈ $498.90K	-89.89%
2014-12-31	₩7.28 Billion ≈ $4.93 Million	--

About GenoFocus Inc

KQ:187420 Korea Specialty Chemicals

Market Cap

$42.40 Million

₩62.57 Billion KRW

Market Cap Rank

#22314 Global

#1418 in Korea

Share Price

₩2130.00

Change (1 day)

-11.98%

52-Week Range

₩1373.00 - ₩3310.00

All Time High

₩17350.00